Kathleen Wesa, MD
Sloan-Kettering Institute for Cancer Research
Clinical Title: Vitamin D Levels in Stage IV Colorectal Cancer Patients: A Phase II Study
Description: Determine if it is clinically possible to achieve and maintain normal serum Vitamin D levels in patients with metastatic colon cancer on front-line treatment.
The purpose of this study is to find out what effects, good and/or bad, vitamin D blood levels has on stage IV colorectal cancer. Tbe doctors want to see if it is possible to increase low vitamin D levels into normal range using vitamin D supplements taken by mouth. Low vitamin D levels have been associated with worse outcomes in persons who have cancer. Low vitamin D may also cause people to have symptoms such as pain and fatigue. We want to see if increasing low vitamin D levels will help improve cancer outcomes. Vitamin D is routinely repleted in all subjects known to be vitamin D deficient. Therefore, the treatment given would be considered standard of care.
Status: Active Trial
Accepting Patients? No
NIH Clinical Trial Link: http://clinicaltrials.gov/ct2/show/NCT01074216?term=kathleen+wesa&rank=2« Back to Funded Clinical Trials
One American dies every 57 seconds from cancer.
These are loved ones, not statistics.
Demanding it all!
Funding innovative cancer research for
Treatments. Cures. Life.